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10 ABSTRACT: The C-terminal domain of cobalamin-dependent methionine synthase
11 (MetH) has an essential role in catalyzing the reactivation of the enzyme following the
12 oxidation of its cobalamin cofactor. This reactivation occurs through reductive
13 methylation of the cobalamin using S-adenosylmethionine (AdoMet) as the methyl
14 donor. Herein, we examine the molecular recognition of AdoMet by the MetH
15 reactivation domain utilizing structural, biochemical, and computational approaches.
16 Crystal structures of the Escherichia coli MetH reactivation domain in complex with
17 AdoMet, the methyl transfer product S-adenosylhomocysteine (AdoHcy), and the
18 AdoMet analogue inhibitor sinefungin illustrate that the ligands exhibit an analogous
19 conformation within the solvent-exposed substrate binding cleft of the enzyme. AdoMet
20 binding is stabilized by an intramolecular sulfur−oxygen chalcogen bond between the sulfonium and carboxylate groups of the
21 substrate and by water-mediated carbon−oxygen hydrogen bonding between the sulfonium cation and the side chains of
22 Glu1097 and Glu1128 that bracket the substrate binding cleft. AdoMet and sinefungin exhibited similar binding aﬃnities for the
23 MetH reactivation domain, whereas AdoHcy displayed an aﬃnity for the enzyme that was an order of magnitude lower.
24 Mutations of Glu1097 and Glu1128 diminished the AdoMet/AdoHcy binding selectivity ratio to approximately 2-fold,
25 underscoring the role of these residues in enabling the enzyme to discriminate between the substrate and product. Together,
26 these ﬁndings indicate that Glu1097 and Glu1128 in MetH promote high-aﬃnity recognition of AdoMet and that sinefungin and
27 potentially other AdoMet-based methyltransferase inhibitors can abrogate MetH reactivation, which would result in oﬀ-target
28 eﬀects associated with alterations in methionine homeostasis and one-carbon metabolism.
29 Cobalamin-dependent methionine synthase (MetH) is a30 dynamic multidomain enzyme that plays a central role in
31 one-carbon metabolism by catalyzing the methylation of
32 homocysteine to methionine using methyltetrahydrofolate
33 (CH3-H4folate). In MetH, this reaction occurs through the
34 transfer of a methyl group from CH3-H4folate to cob(I)alamin
35 [Co(I)Cbl] to form CH3-Co(III)Cbl, which subsequently
36 methylates homocysteine to yield methionine.1−3 During
37 turnover under aerobic conditions, Co(I)Cbl is oxidized to
38 Co(II)Cbl every ∼2000 reactions, inactivating the enzyme.4
39 MetH activity is restored through a one-electron reduction of
40 Co(II)Cbl to Co(I)Cbl by MetH reductase, coupled with S-
41 adenosylmethionine (AdoMet)-dependent methylation of the
42 coenzyme by the C-terminal reactivation domain of MetH. The
43 methionine generated by MetH is utilized in protein synthesis
44 and the biosynthesis of AdoMet, the predominant methyl
45 donor utilized in metabolic pathways, cellular signaling, and
46 gene regulation. Thus, the reactivation domain of MetH plays
47 an essential role in maintaining methyl homeostasis in
48 biological systems.
49Biochemical and structural studies have provided important
50insights into the mechanism of reactivation of MetH by its C-
51terminal domain. Initial structural characterization of the
52Escherichia coli MetH reactivation domain by Dixon et al.
53revealed that it adopts a crescent-shaped fold that is unique
54from other classes of AdoMet-dependent methyltransferases,
55leading to its categorization as a class II methyltransferase.5,6
56AdoMet binds in a relatively solvent-exposed cleft in the
57concave face of the domain. Two glutamate residues, Glu1097
58and Glu1128, ﬂank the AdoMet binding site but do not directly
59interact with the substrate. However, the proximity of these
60glutamates to AdoMet was proposed to promote substrate
61recognition through electrostatic interactions with the sub-
62strate’s sulfonium cation. Subsequent structural and functional
63studies of MetH have demonstrated that the exposed AdoMet
64binding cleft in the reactivation domain permits the substrate to
65dock with the large planar corrin ring system in the cobalamin
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66 binding domain, facilitating methylation of the cofactor during
67 enzyme reactivation.7−9
68 A recent survey of representative high-resolution crystal
69 structures from several classes of AdoMet-dependent methyl-
70 transferases has revealed the widespread presence of carbon−
71 oxygen (CH···O) hydrogen bonds between the AdoMet methyl
72 group and oxygen atoms with the enzymes’ active sites.10 These
73 interactions have been shown to be important in high-aﬃnity
74 AdoMet recognition and for promoting catalysis in the SET
75 domain class of lysine methyltransferases. Interestingly, the
76 structure of the MetH reactivation domain bound to AdoMet
77 does not exhibit direct CH···O hydrogen bonding between the
78 AdoMet methyl group and the enzyme, in contrast to the case
79 for other classes of methyltransferases. This observation
80 spurred us to examine whether other interactions with the
81 active site are important in conferring substrate speciﬁcity in
82 MetH.
83 ■ EXPERIMENTAL PROCEDURES
84 Reagents. S-Adenosylhomocysteine and sinefungin were
85 purchased from Millipore-Sigma. S-Adenosylmethionine p-
86 toluenesulfonate was purchased from Carbosynth and puriﬁed
87 by ion-exchange chromatography.11 13CH3-AdoMet was
88 enzymatically synthesized using E. coli AdoMet synthetase
89 with methyl-13C-methionine (Cambridge Isotope Laboratories)
90 and adenosine triphosphate and puriﬁed as previously
91 described.11
92 Protein Expression and Puriﬁcation. The cDNA
93 encoding the C-terminal domain of E. coli MetH (residues
94 897−1227; UniProt entry P13009) was cloned into a variant of
95 pET15b with a tobacco etch virus (TEV) protease-cleavable N-
96 terminal hexahistidine tag. The E1097Q and E1128Q
97 mutations were prepared using QuikChange mutagenesis
98 (Agilent) and conﬁrmed using dideoxy sequencing. Expression
99 vectors were transformed into E. coli Rosetta2 DE3 cells
100 (Novagen) cultured in 2×YT medium, and protein expression
101 was induced at 18 °C overnight. The wild-type (WT) MetH
102 reactivation domain and glutamine mutants were puriﬁed using
103 a combination of Co(II) Talon aﬃnity and Superdex 200 gel
104 ﬁltration chromatography (GE Healthcare). Prior to gel
105 ﬁltration puriﬁcation, the protein was incubated with charcoal
106 to remove AdoMet that co-puriﬁed with the enzyme, as
107 previously described.12 The puriﬁed proteins were concen-
108 trated, ﬂash-frozen in liquid nitrogen, and stored at −80 °C.
109 Protein concentrations were determined by their absorbance at
110 280 nm.
111 Crystallization and Structure Determination. The
112 MetH reactivation domain was crystallized using the hanging
113 drop method in 60−100 mM TRIS (pH 7.2−7.5), 300 mM
114 magnesium acetate, and 27−32% PEG 6000, similar to the
115 previously reported crystallization conditions.5 The protein
116 solution contained 15 mg/mL MetH, 10 mM TRIS (pH 7.4),
117 10 mM EDTA, and 3.0 mM AdoMet, 3.0 mM sinefungin, or
118 5.0 mM AdoHcy. X-ray diﬀraction data were collected at Life
119 Sciences Collaborative Access Team beamline 21-ID-G at the
120 Advanced Photon Source Synchrotron at Argonne National
121 Laboratory and were processed using HKL2000.13 Structures of
122 the MetH complexes were determined by molecular replace-
123 ment using Phaser with the coordinates of the E. coli MetH
124 reactivation domain [Protein Data Bank (PDB) entry 1MSK]
125 as the search model.14 Model building, reﬁnement, and
126 validation were performed using Coot and Phenix.15−17
127 Structural ﬁgures were rendered using PyMOL (Schrödinger,
128LLC), and electrostatic surface calculations were performed
129using the APBS plugin for PyMOL.18
130Isothermal Titration Calorimetry (ITC). ITC was
131performed using a MicroCal VP-ITC calorimeter (Malvern
132Instruments) for WT MetH and a MicroCal Auto-iTC200
133instrument (Malvern Instruments) for the MetH E1097Q and
134E1128Q mutants. Titrations were performed using 20 mM
135sodium phosphate (pH 8.0) and 100 mM sodium chloride.
136Experiments with the WT enzyme and AdoMet or sinefungin
137were performed with 60 μM protein and 600 μM ligand,
138whereas the AdoHcy titrations were performed with 200 μM
139protein and 2.2 mM ligand. Experiments using the E1097Q and
140E1128Q mutants utilized 830−940 μM protein and 9.6 mM
141AdoMet, 16.1 mM sinefungin, or 10.1−10.7 mM AdoHcy. The
142sinefungin titrations with the MetH mutants required a higher
143ligand concentration. Control titrations of sinefungin at these
144higher concentrations, which approached the concentration of
145the phosphate buﬀer, exhibited a signiﬁcant background heat,
146potentially because of titration of the amine group in
147sinefungin. To correct for this eﬀect, sinefungin was dissolved
148in buﬀer and the solution was adjusted to pH 8.0 using 200
149mM HCl in 20 mM sodium phosphate and 100 mM sodium
150chloride (ﬁnal concentration) to maintain the phosphate and
151sodium ion concentrations. Data were processed using Origin
152(OriginLab Corp.). Stoichiometries of binding (N values)
153ranged from 0.9 to 1.1.
154Nuclear Magnetic Resonance (NMR) Spectroscopy. All
155NMR experiments were performed on a Bruker Avance III 600
156MHz spectrometer equipped with a 5 mm triple-resonance
157cryogenic probe. Spectra were recorded at 25 °C using 0.2 mM
158
13CH3-AdoMet in 20 mM sodium phosphate, 100 mM NaCl,
159and 10% D2O at pH 7.0 (SET7/9) or pH 8.0 (MetH) and
160referenced relative to the water signal. Data were processed and
161analyzed using NMRPipe and Sparky, respectively.19,20 The
162enzyme-bound chemical shift was determined using 1H−13C
163heteronuclear single-quantum correlation (HSQC) spectra of
164
13C-methyl-labeled AdoMet recorded in the presence and
165absence of a 1.2-fold molar stoichiometric excess of SET7/9 or
166MetH (0.24 mM). 1H−13C band-selective optimized ﬂip angle
167short transient heteronuclear multiple-quantum correlation
168(SOFAST-HMQC) spectra were also recorded to assess the
169relative solvent accessibility of the enzyme-bound AdoMet.
170Quantum Mechanics (QM) Calculations. All quantum
171calculations were performed within the framework of the
172Gaussian-09 set of codes.21 The 6-31+G** basis set was applied
173at the DFT level, using the M06-2X functional.22 Geometries
174were fully optimized under the restriction that certain atoms
175were held in their crystallographic coordinates. Optimizations
176were performed in an aqueous solvent, using the CPCM
177variant23 of self-consistent reaction ﬁeld theory. The binding
178energy, EB, of each complex was evaluated in vacuo as the
179diﬀerence between the energy of the entire complex and the
180sum of the energies of (a) the MeS+(Et)2 and S(Et)2
181monomers, representing AdoMet and AdoHcy, respectively,
182and (b) the propionate and propionamide group and their
183cognate water molecules, mimicking Glu1097 and Glu1128 and
184their corresponding glutamine mutations with the water
185molecules bridging to the ligands.
186■ RESULTS
187To gain molecular insights into its substrate speciﬁcity, we
188determined high-resolution crystal structures of the E. coli
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189 MetH reactivation domain bound to AdoMet, AdoHcy, and the
190 AdoMet analogue inhibitor sinefungin (Table S1). The
191 modeling of the ligands in the structures was veriﬁed using
192 simulated annealing omit maps (Figure S1). Superimposition of
193 the reactivation domain complexes and the previously reported
194 structure of the MetH·AdoMet complex illustrates their high
195 degree of structural similarity, with root-mean-square deviations
f1 196 for the aligned Cα atoms of ≤0.32 Å (Figure 1A). In addition,
197 the structural alignment of the complexes reveals that AdoMet,
198 AdoHcy, and sinefungin adopt nearly identical conformations
199when bound in the enzyme’s solvent-exposed substrate binding
200cleft (Figure 1B). This conformation is distinct from the
201AdoMet binding modes observed in other classes of
202methyltransferases and is stabilized in part by an intramolecular
203S···O chalcogen bond between carboxylate and sulfonium ions
204in the substrate (Figure 1C), analogous to the chalcogen bond
205formed by AdoMet and an asparagine in the lysine
206methyltransferase SET7/9.12 In addition, the AdoMet methyl
207group and the ether O4 atom in the ribose ring are oriented in
208a geometry consistent with an intramolecular CH···O hydrogen
Figure 1. Crystal structures of the MetH complexes. (A) Superimposition of the MetH complexes of AdoMet (green), AdoHcy (pink), sinefungin
(cyan), and the previously determined MetH·AdoMet complex (PDB entry 1MSK, gray). (B) Electrostatic surface of the substrate binding cleft with
AdoMet, sinefungin, and AdoHcy aligned based on the superimposition from panel A. The electrostatic potential is contoured from −5.0 to 5.0 kT/e
with red and blue denoting acidic and basic surfaces, respectively. The positions of Glu1097 and -1128 are labeled, and the ligands are colored
according to the scheme used in panel A. Structures of the MetH substrate binding cleft bound to (C) AdoMet, (D) AdoHcy, and (E) sinefungin.
Conventional hydrogen bonds are depicted by cyan dashes, whereas CH···O hydrogen bonds are denoted as orange dashes. Distances for the
hydrogen bonds formed by the four water molecules (W1−W4) that mediate interactions between the ligands and Glu1097 and Glu1128 are
illustrated. (F) Structural overlay of ligands, Glu1097, Glu1128, and the four water molecules in the AdoMet, AdoHcy, and sinefungin complexes
from the superimposition in panel A. The water molecules and glutamate side chains are colored according to their corresponding ligand.
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209 bond. In addition to these intramolecular interactions, an
210 extensive network of direct and water-mediated hydrogen
211 bonds and van der Waals interactions between AdoMet and the
212 residues composing the binding pocket in the enzyme facilitate
213 substrate recognition. An examination of the AdoHcy and
214 sinefungin complexes reveals an analogous network of
215 intermolecular interactions that promote binding of the enzyme
216 to the product and inhibitor, respectively (Figure 1D,E).
217 Correlatively, superimposition of the three MetH complexes
218 illustrates an analogous conformation adopted by AdoMet,
219 AdoHcy, and sinefungin (Figure 1F).
220 Given the similarity in the ligands’ binding modes and their
221 interactions with MetH reactivation domain, we sought to
222 understand the determinants that confer selectivity in AdoMet
223 recognition. Initial structural studies of the reactivation domain
224 by Dixon et al. suggested Glu1097 and Glu1128 as being
225 important to AdoMet binding (Figure 1C).5 The side chains of
226 these residues are within 6 Å of the sulfur cation of the
227 substrate but do not participate in direct interactions with the
228 sulfonium group. They proposed that electrostatic interaction
229 between the carboxylate groups of Glu1097 and Glu1128 and
230 the AdoMet sulfonium cation would favor binding of the
231 substrate compared to the product AdoHcy in which the
232 sulfonium is replaced by a neutral thioether moiety. Consistent
233 with this observation, electrostatic surface calculations of the
234 MetH reactivation domain illustrate that the substrate binding
235 cleft is relatively acidic, conducive to the recognition of the
236 AdoMet sulfonium cation (Figure 1B).
237 A close inspection of the substrate binding cleft reveals two
238 pairs of water molecules that mediate hydrogen bonding
239 between AdoMet and Glu1097 and Glu1128. For the sake of
240 clarity, we have termed these water molecules W1−W4. W1
241 facilitates CH···O hydrogen bonding between the Glu1097
242 carboxylate group and the AdoMet methyl group and the C4
243 atom in the ribose ring, whereas W2 serves to bridge hydrogen
244 bonding between Glu1097 and the Cβ methylene group of the
245 substrate (Figure 1C). The Cβ and C4 atoms in AdoMet are
246 one carbon atom removed from the sulfur cation but remain
247 partially polarized because of their proximity to the cation and
248 can participate in CH···O hydrogen bonding, albeit more
249 weakly than a carbon atom bonded directly to the sulfur
250 cation.24 W3 and W4 form a CH···O hydrogen bonding bridge
251 between the Glu1128 carboxylate anion and the C5 methylene
252 group in the substrate. In addition, W3 forms an OH···O
253 hydrogen bond to the 3′-hydroxyl group of the ribose ring of
254 AdoMet. A superimposition of the structures of the AdoMet,
255 AdoHcy, and sinefungin complexes illustrates that the four
256 water molecules occupy analogous positions within the
257 substrate binding cleft of the diﬀerent ligand-bound complexes
258 (Figure 1F). Collectively, the structures illustrate that AdoMet,
259 AdoHcy, and sinefungin adopt nearly identical conformations
260 when bound to the MetH reactivation domain and that water
261 molecules serve to bridge the interactions between the AdoMet
262 sulfonium cation and Glu1097 and Glu1128 within the
263 enzyme’s binding cleft.
264 On the basis of our observations in the MetH crystal
265 structures, we sought to further examine the water-mediated
266 CH···O hydrogen bonding between MetH and the AdoMet
267 methyl group in solution. In prior studies with the lysine
268 methyltransferase SET7/9, we employed two-dimensional
269 heteronuclear single-quantum coherence (2D HSQC) spec-
270 troscopy with a 13C-labeled methyl group of AdoMet (13CH3-
271 AdoMet) to detect CH···O hydrogen bonding between the
272substrate’s methyl group and residues within the enzyme’s
273active site. In the 2D HSQC spectrum of the MetH·13CH3-
274AdoMet complex, the 1H chemical shift of the methyl group
275was observed at 3.1 ppm, a 0.1 ppm downﬁeld change
276compared to the reported value of AdoMet free in solution (3.0
277 f2ppm) (Figure 2A).25 This small alteration in the 1H chemical
278shift is consistent with the water-mediated CH···O hydrogen
279bonding of the AdoMet methyl group bound to MetH (Figure
2802A). In contrast, the 1H chemical shift of 13CH3-AdoMet bound
281to the lysine methyltransferase SET7/9 exhibited a marked
282downﬁeld change of 3.8 ppm (Figure 2B), consistent with
283methyl CH···O hydrogen bonding in the active site, as
284previously reported.11 As corroboration for these ﬁndings, a
285cross-peak was recorded in the band-selective optimized ﬂip
286angle short transient heteronuclear multiple quantum coher-
287ence (SOFAST-HMQC)26 spectrum of the MetH·13CH3-
288AdoMet complex, whereas no peak was discernible in the
289spectrum of the SET7/9·13CH3-AdoMet complex (Figure
2902C,D). The SOFAST-HMQC data concur with the relatively
291solvent-exposed proton rich environment of the AdoMet
292binding cleft in MetH and the general depletion of the
293
1H−1H “relaxation sink” around the substrate’s methyl group
294when bound in the active site of SET7/9 (Figure S2).
295Together, the NMR results correlate with the MetH crystal
296structures, illustrating the relative solvent exposure of the
297AdoMet methyl group when bound in the active site.
298Our observations of water-mediated CH···O hydrogen
299bonding between Glu1097 and Glu1128 in MetH and the
300AdoMet sulfonium cation prompted us to examine the
301thermodynamic properties of these interactions and whether
302they contribute to the substrate speciﬁcity of the enzyme. Using
303ITC, we measured the equilibrium dissociation constants (KD)
304and enthalpies of binding (ΔH) of AdoMet, AdoHcy, and
305 f3sinefungin for the WT enzyme (Figure 3 and Figure S3A,B).
306The ITC data illustrate that the MetH reactivation domain
307bound AdoMet and sinefungin with comparable aﬃnity and
308ΔH values, whereas it exhibited a 15-fold lower aﬃnity for
309AdoHcy than for AdoMet, with a corresponding decrease in
310 t1ΔH (Table 1). These results are consistent with the acidic
311surface of the substrate binding cleft and the water-mediated
312hydrogen bonding between the carboxylate anions of Glu1097
313and Glu1128 and the sulfonium and ammonium cations of
314AdoMet and sinefungin, respectively (Figure 1B−D). These
315water-mediated hydrogen bonds would presumably be
316relatively strong because of the positive and negative charges
317of the proton donors and acceptors, respectively. Conversely,
Figure 2. Two-dimensional (A) HSQC and (B) SOFAST-HMQC
spectra of the MetH·13CH3-AdoMet complex and (C) HSQC and (D)
SOFAST-HMQC spectra of the SET7/9·13CH3-AdoMet complex.
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318 AdoHcy would presumably be expected to form weaker water-
319 mediated CH···O hydrogen bonds with the glutamates because
320 of the lack of methyl interactions and its neutral thioester
321 group, consistent with the thermodynamic binding data. To
322further probe these ﬁndings, we substituted Glu1097 and
323Glu1128 with glutamine in MetH and examined the eﬀect of
324these mutations on the binding aﬃnity of the ligands (Figure
325S3C−H). Glutamine mutations were chosen because of their
326propensity to weaken the water-mediated hydrogen bonding to
327the ligands by substituting their side chain carboxylate anions
328with neutral carboxamide groups, while preserving the
329hydrogen bonding networks formed by these residues within
330the active site (Figure S4). The E1097Q and E1128Q
331mutations diminished the binding aﬃnity of AdoMet and
332sinefungin from 4- to 22-fold compared to that of WT MetH,
333whereas binding to AdoHcy was altered by <2-fold. Moreover,
334each glutamine mutation eﬀectively reduced the diﬀerence in
335the enzyme’s binding selectively for AdoMet and AdoHcy to
336approximately 2-fold. Together, these ﬁndings illustrate that the
337water-mediated CH···O hydrogen bonds formed between the
338carboxylate groups of Glu1097 and Glu1128 and the AdoMet
339sulfonium cation are important in conferring recognition of the
340substrate versus the product and that substitution of these
341residues with glutamine abrogates this selectively.
342To further investigate these ﬁndings, we performed quantum
343mechanical calculations to investigate the CH···O hydrogen
344bonding between AdoMet and AdoHcy and the glutamates
345within the MetH substrate binding cleft. To assess the
346individual contributions of Glu1097 and Glu1128 to AdoMet
347and AdoHcy recognition, pairwise models of the active site
348were generated comprising the ligands, each glutamate, and the
349cognate water molecules that mediate CH···O hydrogen
350bonding. The active site models were based upon the
351coordinates of the crystal structures of MetH bound to the
352 f4substrate and product (Figure 4 and Figure S5). The AdoMet
353sulfonium cation and AdoHcy thioester were represented as
354MeS+(Et)2 and S(Et)2 monomers, respectively, as previously
355described.12,27 Glu1097 and Glu1128 were modeled as
356propionate groups, and the corresponding glutamine sub-
357stitutions were represented as propionamide moieties using the
358coordinates of the glutamate side chains, with the carboxamide
359oxygen atoms oriented toward the ligands to retain an
360analogous pattern of water-mediated CH···O hydrogen
361bonding. For the models representing the WT enzyme, the
362heavy atoms of the ligands and the water molecules were
363constrained to their crystallographic coordinates, whereas
364certain carbon atoms in the propionate were constrained to
365maintain the glutamate side chain conformations observed in
366the crystal structures. For the propionamide-containing models,
367the same atoms were held ﬁxed in the ligands and
368propionamide groups. However, the water molecules were
369left unrestrained to allow the optimization of their positions
370relative to the propionamide monomers, with the exception of
371W4 in the S(Et)2 model that strayed into a position that would
372sterically clash with atoms in the crystal structures that were not
373included in the models.
374Once the active site models were generated, the binding
375energy (EB) for each complex was evaluated as the diﬀerence in
376energy between the full complex on one hand and the sum of
377the ligand and the interacting residue and solvent on the other.
378We then computed the diﬀerences in the EB values for the
379MeS+(Et)2 and S(Et)2 complexes {ΔEB [MeS+(Et)2 − S(Et)2]}
380and the propionate to propionamide substitutions correspond-
381ing to the E1097Q and E1128Q mutations (ΔEB [E − Q])
382(Table 1). Overall, the trends observed in the EB values for the
383models correlate with the AdoMet and AdoHcy binding
384aﬃnities and ΔH values observed for WT MetH and the
Figure 3. ITC titration of the WT MetH reactivation domain and
AdoMet. The top panel shows the titration of AdoMet into the MetH
solution, and the bottom panel illustrates the curve ﬁtted to the
binding isotherm.
Table 1. ITC Data and QM-Calculated Binding Energies
(EB) for Ligand Binding by WT MetH and the E1097Q and
E1128Q Mutants
KD (μM)
WT E1097Q E1128Q
AdoMet 1.43 ± 0.05 6.10 ± 0.68 17.5 ± 1.0
AdoHcy 20.8 ± 0.2 15.0 ± 0.5 38.2 ± 1.0
sinefungin 2.04 ± 0.07 17.7 ± 1.56 44.8 ± 2.51
ΔH (kcal mol−1)
WT E1097Q E1128Q
AdoMet −23.92 ± 0.10 −19.43 ± 0.16 −15.65 ± 0.09
AdoHcy −15.30 ± 0.03 −11.95 ± 0.04 −11.22 ± 0.04
sinefungin −18.59 ± 0.09 −17.02 ± 0.17 −14.63 ± 0.13
QM binding energy (kcal mol−1)
E1097 Q1097
ΔEB [E
− Q] E1128 Q1128
ΔEB [E
− Q]
MeS+(Et)2
complex
energy
87.69 19.19 68.50 73.41 29.30 44.11
S(Et)2 complex
energy
8.45 7.25 1.20 6.30 3.53 2.77
ΔEB [MeS+(Et)2
− S(Et)2]
79.24 11.94 67.11 25.77
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385 E1097Q and E1128Q mutants. There is a substantial decrease
386 in the ΔEB [MeS+(Et)2 − S(Et)2] values upon substitution of
387 the propionate group with propionamide for both the Glu1097
388 and Glu1128 models. This ﬁnding is consistent with the ITC
389 data illustrating that the diﬀerences in the binding aﬃnities for
390 AdoMet and AdoHcy are substantially diminished in the
391 E1097Q and E1128Q mutants compared to that of WT MetH.
392 Correlatively, the values of ΔEB [E − Q] are substantially larger
393 for the MeS+(Et)2 models than for the S(Et)2 models for both
394 glutamate positions, in agreement with the stronger apparent
395 eﬀect of the E1097Q and E1128Q mutants on the binding
396 aﬃnities and ΔH values for AdoMet than on those of AdoHcy.
397 Taken together, the strongest binding energies are observed
398 when both the sulfonium cation and carboxylate anions are
399 present in the models, whereas the interaction energies are
400 diminished upon substitution of neutral thioether or carbox-
401 amide groups. These results indicate that the water-mediated
402 hydrogen bonding serves as a conduit for the electrostatic
403 interactions between the AdoMet sulfonium cation and the
404 Glu1097 and Glu1128 carboxylate anions and that the strength
405 of these interactions is signiﬁcantly attenuated when one or
406 both ions are substituted by a neutral moiety.
407 ■ DISCUSSION
408 Prior studies of diﬀerent classes of AdoMet-dependent
409 methyltransferases have described the presence of CH···O
410 hydrogen bonding between the AdoMet sulfonium cation and
411 residues within the enzymes’ active sites.10 In SET domain
412 lysine methyltransferases, these interactions have been shown
413 to be important for high-aﬃnity recognition of AdoMet,
414enabling these enzymes to distinguish the substrate from the
415product AdoHcy, thus mitigating product inhibition.10,27,28 In
416contrast, the substrate binding cleft of MetH utilizes a diﬀerent
417mode of recognition wherein active site glutamates form water-
418mediated CH···O hydrogen bonds with the AdoMet sulfonium
419cation. The electrostatic nature of these hydrogen bonds is
420important, as the removal of one or both charges by glutamate
421to glutamine mutation or substitution of the AdoMet sulfonium
422cation by the thioether in AdoHcy diminished the binding
423aﬃnity, ΔH values, and the QM-calculated EB values (Table 1).
424These data suggest a model wherein water-mediated CH···O
425hydrogen bonding between the AdoMet sulfonium cation and
426acidic residues within the active site of a methyltransferase may
427serve to enhance substrate recognition. In contrast, water-
428bridged interactions involving amino acids with neutral polar
429side chains would potentially form weaker hydrogen bonds that
430do not contribute to selective AdoMet recognition, consistent
431with the eﬀect of the glutamate to glutamine substitutions in
432MetH (Table 1). These ﬁndings justify further investigation of
433how acidic residues may facilitate AdoMet recognition in other
434methyltransferases.
435These results also oﬀer new insights into how the AdoMet/
436AdoHcy ratio may govern MetH activity in cells. The E. coli
437MetH reactivation domain displayed a 15-fold higher aﬃnity
438for AdoMet than for AdoHcy (Table 1). This diﬀerence in
439selectivity is achieved in part by water-mediated hydrogen
440bonding between AdoMet and Glu1097 and Glu1128 in the
441enzyme. In mammalian MetH, the residue corresponding to
442Glu1128 in the E. coli enzyme is substituted with a leucine.29
443On the basis of the eﬀects of the E. coli MetH E1128Q mutant
444(Table 1), the leucine substitution would presumably weaken
445its ability to discriminate between AdoMet and AdoHcy,
446rendering it more susceptible to product inhibition. Mammalian
447studies investigating AdoMet and AdoHcy concentrations have
448reported AdoMet/AdoHcy ratios ranging from 2 to 11,
449depending on the tissue type.30,31 Metabolic changes that
450increase the concentration of AdoHcy and decrease the
451AdoMet/AdoHcy ratio would potentially inhibit the MetH
452reactivation domain, thus resulting in diminished reactivation of
453the enzyme with concomitant alterations in the cellular methyl
454cycle.
455Prior studies of a disulﬁde-stabilized C-terminal construct of
456E. coliMetH comprising the cobalamin binding and reactivation
457domains have revealed that Glu1097 also has a catalytic role in
458the reactivation cycle.8,9 The structure of this C-terminal MetH
459construct bound to cobalamin and AdoHcy illustrates that the
460side chains of Glu1097 and Tyr1139 form hydrogen bonds to a
461water molecule coordinated to the Co ion in the cofactor.
462These interactions stabilize the four-coordinate state of
463Co(II)Cbl, promoting the one-electron reduction of Co(II)Cbl
464to Co(I)Cbl. Structures of the C-terminal construct determined
465in the absence and presence of AdoHcy indicate that the side
466chain of Glu1097 undergoes a change in conformation to
467engage in hydrogen bonding with the Co-coordinated water
468molecule when AdoHcy is bound, which would also
469presumably occur when AdoMet is present. Thus, Glu1097,
470which is invariant in MetH, may serve two functions in the
471enzyme: (1) to enhance AdoMet binding aﬃnity through
472water-mediated CH···O hydrogen bonding and (2) to
473modulate the reduction potential of Co(II)Cbl by hydrogen
474bonding to the Co-bound water molecule.
475Finally, our results have important ramiﬁcations with respect
476to the development of AdoMet analogues as competitive
Figure 4. Optimized geometry for the minimal active site models used
in the QM calculations to determine the binding energies for the (A)
AdoMet and Glu1097 and (B) AdoMet and Glu1128 complexes. The
AdoMet sulfonium cation was modeled as MeS+(Et)2, and the
glutamate side chains were represented by propionate groups. The
ligand heavy atom positions (carbon and sulfur atoms) were
constrained to their X-ray coordinates, as were the oxygen atoms in
the water molecules and carbon atoms in the propionate monomers
that are denoted by asterisks. Conventional and CH···O hydrogen
bonds are depicted as cyan and orange dashed lines, respectively, with
H···O distances denoted.
Biochemistry Article
DOI: 10.1021/acs.biochem.8b00375
Biochemistry XXXX, XXX, XXX−XXX
F
477 inhibitors of methyltransferases. Several of these inhibitors
478 utilize sinefungin, a natural product pan-methyltransferase
479 inhibitor, as a scaﬀold given its isostericity with AdoMet.32−36
480 Given that sinefungin recognizes the MetH reactivation domain
481 with an aﬃnity comparable to that of AdoMet (Table 1),
482 analogues derived from it may also bind to the enzyme,
483 particularly because of the solvent exposure of the substrate
484 binding cleft that can accommodate chemical derivatizations of
485 the inhibitor (Figure S2). Sinefungin has been reported to
486 cause severe nephrotoxicity in mammalian models of
487 cryptosporidiosis and trypanosomiasis.37,38 It is conceivable
488 that this toxicity is due to not only widespread inhibition of
489 AdoMet-dependent methyltransferases but also abrogation of
490 MetH reactivation, disrupting methionine biosynthesis and the
491 cellular methyl cycle. In light of these ﬁndings, it would be
492 advisable that future eﬀorts to devise AdoMet-based inhibitors
493 of methyltransferases evaluate whether these compounds
494 inhibit the reactivation domain of MetH to circumvent oﬀ-
495 target eﬀects of these molecules in vivo.
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